type here...

CATEGORIES

Patient Zone

LATEST

1...525354...59Page 53 of 59

TRENDING

EDITORS CHOICE

Dr. Sherrill Sellman on Medika’s Quack Scale

Medika Life -
Dr. Sherrill Sellman scores 5 out of 5 on Medika's Quack Scale. She poses a high risk to the general public and we recommend against following any of her advice.

FDA Approval of New Drug for Alzheimer’s Offers Hope

Dr Jeff Livingston -
The FDA approves Aduhelm for the treatment of early Alzheimer's disease. Aduhelm targets brain plaque formation to slow the rate of cognitive decline.

Before Looking at the Results of the Paper on MDMA to Treat PTSD…

James Coyne -
So what really is the truth about MDMA and PTSD. Does this research published in Science hold up to scrutiny is is there a problem. Watch this space

You Can’t Hack Your Way to Health

Elizabeth Knight PhD -
What’s the one best thing I can do for my health? This question tends to come up around the new year. In my clinical...

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories